Clinical Trials
2 trialsNCT07039526 2026-06-05
Single Dose Investigator Initiated Pilot Study to Investigate CYTALUX (Pafolacianine) for Intraoperative Detection of Malignant Tissue in Subjects Undergoing Surgical Resection for Cancer.
University of Texas Southwestern Medical Center
Phase 2 Recruiting
NCT06434909 2026-06-01
CYTALUXâ„¢for the Intraoperative Imaging of Prostate Cancer
Indiana University
Phase 2 Completed